Physician

Jiang Cui, M.D.

According to 2025 Medicare claims, Jiang Cui, M.D. (NPI: 1447331152) practices cardiac electrophysiology in the Memphis, TN-MS-AR market, with the plurality of this provider's patient population coming from De Soto, MS. This provider's primary affiliated billing organization is STERN CARDIOVASCULAR FOUNDATION, INC (NPI: 1316242266; TIN: 274396698) and primary practice location at 38671-9998. Cui is affiliated with the Baptist Connected Care Solutions, Inc. (ACO ID: A5693), participating under the MSSP model.

Cui's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,635 traditional Medicare patients, billed 7,958 HCPCS/CPT codes, and received $341,853 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,213 prescription claims across 675 beneficiaries totaling $944,201 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 12 claims. Open Payments data shows 49 records totaling $3,787. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $130,048 to $944,201. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $6,480 to $3,279.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,317	4,571	$316,501
2016	1,266	4,316	$300,095
2017	1,333	5,054	$312,847
2018	1,796	6,968	$348,789
2019	1,835	8,144	$400,777
2020	1,777	7,840	$373,786
2021	1,698	7,487	$345,705
2022	1,632	6,849	$270,008
2023	1,421	5,878	$256,035
2024	1,635	7,958	$341,853

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	341	3,138	$130,048
2016	404	3,384	$155,747
2017	412	3,911	$206,015
2018	430	4,373	$274,450
2019	449	4,321	$345,556
2020	461	3,894	$449,903
2021	550	4,180	$545,539
2022	573	4,382	$610,351
2023	569	4,522	$738,062
2024	675	5,213	$944,201

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	13	$209
2016	N/R	15	$28,244
2017	N/R	29	$1,152
2018	N/R	41	$26,113
2019	N/R	32	$2,181
2020	N/R	11	$784
2021	N/R	33	$1,703
2022	N/R	46	$1,840
2023	N/R	12	$641
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	395	563	$83
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	451	454	$49
93280	Programming of dual lead pacemaker system	237	270	$25
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	456	1,120	$21
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	593	1,426	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	607	26,852	$518,112
Xarelto	Rivaroxaban	109	7,220	$131,306
Entresto	Sacubitril/Valsartan	110	5,640	$116,385
Jardiance	Empagliflozin	46	2,700	$50,469
Farxiga	Dapagliflozin Propanediol	31	1,445	$27,728

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	49	$3,787	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jiang Cui, M.D.?

Tedicare shows public-source Medicare data for Jiang Cui, M.D. (NPI 1447331152), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jiang Cui, M.D. have ACO affiliation data?

Jiang Cui, M.D. is shown with ACO affiliation data for Baptist Connected Care Solutions, Inc. (MSSP, ACO ID A5693).

What billing organization is linked to Jiang Cui, M.D.?

Jiang Cui, M.D. is linked to STERN CARDIOVASCULAR FOUNDATION, INC (billing NPI 1316242266) in the available physician profile data.

Does Jiang Cui, M.D. have Open Payments data?

Jiang Cui, M.D. has 49 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.